Top Buy
| Wertpapier | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| ProQR Therapeutics N.V. | 8 | 1 | 3 | 1 | 1,83 € | 3,03 € | 65,90 % |
| Cara Therapeutics Inc. | 9 | 1 | 1 | 0 | 0,66 € | 4,62 € | 595,49 % |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | 62,52 € | 86,77 € | 38,79 % |
| MacroGenics Inc. | 12 | 1 | 4 | 1 | 4,11 € | 12,42 € | 202,45 % |
| Chromadex Corp | 11 | 1 | 1 | 0 | 3,16 € | 5,58 € | 76,45 % |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | 39,60 € | 50,00 € | 26,26 % |
| BeiGene Ltd ADR | 9 | 1 | 2 | 0 | 149,00 € | 241,54 € | 62,11 % |
| Cytokinetics Inc. | 27 | 1 | 4 | 0 | 55,00 € | 85,64 € | 55,72 % |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | 38,00 € | 84,74 € | 123,01 % |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | 1,65 € | 3,70 € | 124,24 % |
| Novocure Ltd | 1 | 1 | 0 | 0 | 18,79 € | - | - |
| Xencor Inc. | 10 | 1 | 2 | 0 | 22,60 € | 32,58 € | 44,15 % |
| Stoke Therapeutics Inc | 15 | 1 | 2 | 0 | 11,80 € | 21,00 € | 78,00 % |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | 119,00 € | 124,92 € | 4,98 % |
| Johnson & Johnson | 32 | 1 | 3 | 0 | 139,90 € | 196,74 € | 40,63 % |
| EyePoint Pharmaceuticals Inc. | 18 | 1 | 4 | 0 | 11,33 € | 27,80 € | 145,40 % |
| AnaptysBio Inc | 9 | 1 | 4 | 0 | 23,20 € | 45,21 € | 94,87 % |
| Zoetis Inc. A | 23 | 1 | 5 | 0 | 156,06 € | 200,06 € | 28,19 % |
| Dr. Reddy's Laboratories Ltd. ADR | 6 | 1 | 1 | 0 | 64,00 € | 74,65 € | 16,63 % |
| Regeneron Pharmaceuticals Inc. | 35 | 1 | 4 | 0 | 910,40 € | 959,41 € | 5,38 % |
| G1 Therapeutics | 15 | 1 | 2 | 0 | 4,29 € | 10,56 € | 145,90 % |
| Abeona Therapeutics Inc. | 3 | 1 | 1 | 0 | 3,90 € | 34,41 € | 782,37 % |
| Incyte Corp. | 12 | 2 | 3 | 0 | 52,74 € | 78,42 € | 48,70 % |
| Phibro Animal Health Corp. A | 4 | 2 | 0 | 1 | 16,60 € | 12,06 € | -27,33 % |
| Akebia Therapeutics Inc. | 8 | 2 | 1 | 0 | 1,13 € | 3,64 € | 221,66 % |